latest news in Novo Nordisk

American Demand for Weight Loss Drugs Prompts Denmark to Double Economic Growth Forecast

American Demand for Weight Loss Drugs Prompts Denmark to Double Economic Growth Forecast

Copenhagen, Thursday, 24 September 2026.
Danmarks Nationalbank doubled Denmark’s 2026 economic growth forecast to 4%, driven by soaring U.S. demand for Novo Nordisk’s weight loss medications Wegovy and Ozempic.